$4,750.00
Symptomatic benign prostatic hyperplasia (BPH) and prostatitis affect more than 100 million men worldwide, lowering quality of life with painful symptoms that can be difficult to manage.
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for biopsy devices.
Visit Meddevicetracker to view the latest analysis and updates for the biopsy devices market.
EXECUTIVE SUMMARY …………………………………………………………………………. ES-1
i. Methodology ……………………………………………………………………….. ES-5
Exhibit ES-1: Global biopsy devices market, share by country/region, 2016 ……. ES-3
Exhibit ES-2: Global biopsy devices market, share by product type, 2016 ………. ES-4
1. CANCER STATISTICS UPDATE ………………………………………………………. 1-1
1.1 Cancer prevalence and mortality ………………………………………………. 1-1
1.2 Bibliography …………………………………………………………………………. 1-10
Exhibit 1-1: Age-standardized cancer incidence and mortality cases (000s), 2012 …………………………………………………… 1-3
Exhibit 1-2: Highest age-standardized rates for all cancers, top 10 countries, 2012 …………………………………………………………………. 1-5
Exhibit 1-3: Age-standardized rates of cancer, select countries, 2012 …………….. 1-6
Exhibit 1-4: Estimated incidence of the five most common cancer types worldwide, 2012 ……………………………………………………………. 1-8
Exhibit 1-5: Estimated number of cancer deaths, select countries, 2012 …………. 1-9
2. BIOPSY DEVICES AND BIOPSY GUIDANCE SYSTEMS…………………….. 2-1
2.1 Core needle biopsy …………………………………………………………………. 2-3
2.1.1 Products …………………………………………………………………. 2-3
2.2 Fine needle aspiration biopsy …………………………………………………… 2-5
2.2.1 Products …………………………………………………………………. 2-5
2.3 Vacuum-assisted biopsy ………………………………………………………….. 2-7
2.3.1 Products …………………………………………………………………. 2-7
2.4 Endoscopic biopsy………………………………………………………………….. 2-8
2.5 Open/surgical biopsy …………………………………………………………….. 2-10
2.6 Bone and bone marrow biopsy ……………………………………………….. 2-10
2.6.1 Products ……………………………………………………………….. 2-11
2.7 Other types of biopsy products ……………………………………………….. 2-11
2.8 Biopsy guidance systems ………………………………………………………. 2-13
2.8.1 Products ……………………………………………………………….. 2-15
2.9 Emerging products/technologies …………………………………………….. 2-16
2.10 Bibliography …………………………………………………………………………. 2-19
Exhibit 2-1: Select images of core needle biopsy devices ……………………………… 2-4
Exhibit 2-2: Select images of fine needle aspiration devices ………………………….. 2-6
Exhibit 2-3: Select images of vacuum-assisted biopsy devices ………………………. 2-9
Exhibit 2-4: Select images of bone and bone marrow biopsy devices ……………. 2-12
Exhibit 2-5: Select images of biopsy forceps ……………………………………………… 2-14
Exhibit 2-6: Select images of biopsy guidance systems ………………………………. 2-17
3. BIOPSY PRODUCTS MARKET ………………………………………………………… 3-1
3.1 Global competitors ………………………………………………………………… 3-12
3.1.1 Biopsy guidance systems competitive analysis …………… 3-12
3.1.2 Needle-based biopsy products competitive analysis ……. 3-14
3.2 Market forecast: US ………………………………………………………………. 3-16
3.2.1 Biopsy guidance systems market: US ……………………….. 3-20
3.2.2 Needle-based biopsy products market: US ………………… 3-21
3.2.2.1 Competitors …………………………………………….. 3-24
3.2.3 Other biopsy products market: US ……………………………. 3-24
3.3 Market forecast: five major EU markets ……………………………………. 3-24
3.3.1 Biopsy guidance systems market: five major EU markets ……………………………………………………………. 3-28
3.3.2 Needle-based biopsy products market: five major EU markets …………………………………………………………………. 3-30
3.3.2.1 Competitors …………………………………………….. 3-32
3.3.3 Other biopsy products market: five major EU markets …. 3-32
3.4 Market forecast: Japan ………………………………………………………….. 3-35
3.4.1 Biopsy guidance systems market: Japan …………………… 3-38
3.4.2 Needle-based biopsy products market: Japan ……………. 3-39
3.4.2.1 Competitors …………………………………………….. 3-42
3.4.3 Other biopsy products market: Japan ………………………… 3-42
3.5 Market forecast: RoW ……………………………………………………………. 3-42
3.5.1 Biopsy guidance systems market: RoW …………………….. 3-47
3.5.2 Needle-based biopsy products market: RoW ……………… 3-48
3.5.2.1 Competitors …………………………………………….. 3-50
3.5.3 Other biopsy products market: RoW …………………………. 3-53
3.6 Bibliography …………………………………………………………………………. 3-55
Exhibit 3-1: Biopsy products, global market forecast, 2016-21 ……………………….. 3-2
Exhibit 3-2: Global biopsy product sales by product segment, combined market forecast ($m), 2016-21 ……………………………………………………………. 3-3
Exhibit 3-3: Average sale price for biopsy products ………………………………………. 3-5
Exhibit 3-4: Total biopsy product sales by end-user, combined market forecast ($m), 2016-21 ………………………………………………………………………… 3-8
Exhibit 3-5: Global biopsy product sales by country/region, combined market forecast ($m), 2016-21 ………………………………………………………….. 3-10
Exhibit 3-6: Global biopsy products market, share by country/region, 2016 ……. 3-13
Exhibit 3-7: Global biopsy guidance systems market, share by supplier, 2016 ………………………………………………………………….. 3-15
Exhibit 3-8: Global needle-based biopsy products market, share by supplier, 2016 ………………………………………………………………….. 3-17
Exhibit 3-9: US biopsy products, combined market forecast, 2016-21 …………… 3-19
Exhibit 3-10: US biopsy guidance systems, market forecast, 2016-21 …………….. 3-22
Exhibit 3-11: US needle-based biopsy products, market forecast, 2016-21 ……… 3-23
Exhibit 3-12: US needle-based biopsy products market, share by supplier, 2016 ………………………………………………………………….. 3-25
Exhibit 3-13: US other biopsy products, market forecast, 2016-21………………….. 3-26
Exhibit 3-14: Five major EU markets biopsy products, combined market forecast, 2016-21 …………………………………………………………………. 3-29
Exhibit 3-15: Five major EU markets biopsy guidance systems, market forecast, 2016-21 …………………………………………………………………. 3-31
Exhibit 3-16: Five major EU markets needle-based biopsy products, market forecast, 2016-21 …………………………………………………………………. 3-33
Exhibit 3-17: Five major EU markets needle-based biopsy products market, share by supplier, 2016 …………………………………………………………. 3-34
Exhibit 3-18: Five major EU markets other biopsy products, market forecast, 2016-21 …………………………………………………………………. 3-36
Exhibit 3-19: Japan biopsy products, combined market forecast, 2016-21 ………. 3-37
Exhibit 3-20: Japan biopsy guidance systems, market forecast, 2016-21 ………… 3-40
Exhibit 3-21: Japan needle-based biopsy products, market forecast, 2016-21 …. 3-41
Exhibit 3-22: Japan needle-based biopsy products market, share by supplier, 2016 ………………………………………………………………….. 3-43
Exhibit 3-23: Japan other biopsy products, market forecast, 2016-21 ……………… 3-44
Exhibit 3-24: Rest of the World biopsy products, combined market forecast, 2016-21 …………………………………………………………………. 3-46
Exhibit 3-25: Rest of the World biopsy guidance systems, market forecast, 2016-21 …………………………………………………………………. 3-49
Exhibit 3-26: Rest of the World needle-based biopsy products, market forecast, 2016-21 …………………………………………………………………. 3-51
Exhibit 3-27: Rest of World needle-based biopsy products market, share by supplier, 2016 ………………………………………………………………….. 3-52
Exhibit 3-28: Rest of the World other biopsy products, market forecast, 2016-21 …………………………………………………………………. 3-54
APPENDIX: COMPANY LISTING ……………………………..A-1
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!